A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 2,309,200 shares of TEVA stock, worth $51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,309,200
Previous 3,956,700 41.64%
Holding current value
$51 Million
Previous $64.3 Million 35.28%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $26.9 Million - $32.2 Million
1,700,049 Added 96.13%
3,468,462 $62.5 Million
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $42.7 Million - $58.1 Million
-3,341,713 Reduced 65.39%
1,768,413 $28.7 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $69.3 Million - $93.7 Million
-6,493,437 Reduced 55.96%
5,110,126 $72.1 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $69.6 Million - $91.1 Million
8,573,014 Added 282.89%
11,603,563 $121 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $10.9 Million - $15.6 Million
-1,455,496 Reduced 32.44%
3,030,549 $30.9 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $36.5 Million - $48 Million
-5,065,306 Reduced 53.03%
4,486,045 $33.8 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $57.5 Million - $78.2 Million
6,879,779 Added 257.52%
9,551,351 $84.5 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $1.15 Million - $1.37 Million
144,815 Added 5.73%
2,671,572 $24.4 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $48.8 Million - $85.1 Million
-7,119,914 Reduced 73.81%
2,526,757 $20.4 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $57.4 Million - $80.9 Million
7,778,203 Added 416.29%
9,646,671 $72.5 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $3.7 Million - $4.74 Million
-505,182 Reduced 21.28%
1,868,468 $17.5 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $4.54 Million - $5.86 Million
-574,697 Reduced 19.49%
2,373,650 $19 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $749,088 - $909,990
-89,390 Reduced 2.94%
2,948,347 $28.7 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $10.7 Million - $12.5 Million
1,084,671 Added 55.54%
3,037,737 $30.1 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $5.98 Million - $7.41 Million
578,445 Added 42.08%
1,953,066 $22.5 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $7.6 Million - $9.75 Million
-882,701 Reduced 39.1%
1,374,621 $13.3 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $17.2 Million - $25.5 Million
2,005,712 Added 797.15%
2,257,322 $20.3 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $6.51 Million - $10.5 Million
-802,124 Reduced 76.12%
251,610 $3.1 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $8.02 Million - $16.1 Million
-1,198,779 Reduced 53.22%
1,053,734 $9.46 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $11.3 Million - $18.6 Million
1,734,238 Added 334.62%
2,252,513 $22.1 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $3.87 Million - $6.04 Million
-628,822 Reduced 54.82%
518,275 $3.57 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $4.81 Million - $9.32 Million
-592,724 Reduced 34.07%
1,147,097 $10.6 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $10.6 Million - $13.6 Million
-680,415 Reduced 28.11%
1,739,821 $0
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $4 Million - $6.54 Million
-274,342 Reduced 10.18%
2,420,236 $37.3 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $24.3 Million - $29.7 Million
1,156,121 Added 75.15%
2,694,578 $0
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $19.7 Million - $29 Million
1,175,143 Added 323.45%
1,538,457 $0
Q1 2018

May 11, 2018

BUY
$16.68 - $22.07 $1.77 Million - $2.35 Million
106,321 Added 41.37%
363,314 $6.21 Million
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $2.79 Million - $4.74 Million
-248,172 Reduced 49.13%
256,993 $4.87 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $7.78 Million - $16.3 Million
505,165
505,165 $8.89 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.